Related Experiment Video
Updated: Aug 13, 2026

Immunofluorescence to Monitor the Cellular Uptake of Human Lactoferrin and its Associated Antiviral Activity Against the Hepatitis C Virus
Published on: October 1, 2015
[Cyclopheron pretreatment in opisthorchiasis management in patients with viral hepatitis C]
Aim:
To assess efficacy of cyclopheron (Polysan production) as opisthorchiasis pretreatment in patients with chronic viral hepatitis C (CHC).
Material And Methods:
Fifteen CHC patients received cyclopheron by 6 month scheme before dehelminthization. The effect was evaluated by dynamics of clinical symptoms, results of functional hepatic tests, levels of autoantibodies to antigens of native and denaturated DNA, CIC and lactoferrin. Fourteen control patients did not receive pretreatment with cyclopheron.
Results:
The study group patients exhibited a relief of asthenovegetative and pain syndromes, aminotranspherases lowered to normal in 11 patients, minimal activity of cytolytic syndrome--in 4 patients. Lactoferrin normalized in all the patients, coefficient of autoantibodies to antigens of native and denaturated DNA fell two-fold. No significant improvement in the clinical and laboratory picture was seen in the controls.
Conclusion:
Cyclopheron in patients with CHC combination with chronic opisthorchiasis is recommended as pretreatment before dehelminthization.
Related Concept Videos
Inhibitors of Viral Protein Synthesis
Hepatitis
Viral Hepatitis I: Introduction
Antiviral Nucleoside Inhibitors
Retrovirus Life Cycles
Antiprotozoal Agents
